CAR T cells derived from a novel, high-affinity anti-CLL-1 monoclonal antibody exhibit a significant anti-AML effect. - Kida S; Suga M; Yamaguchi Y; Ikeda S; Kogue Y; Kawamoto R; Shibata K; Tsutsumi K; Murakami H; Mizuta E; Mizutani Y; Hosen N (Cancer immunology, immunotherapy : CII, 2026)